Further to its intimation made earlier with regard to Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended 31st December, 2025 (‘Financial Results’), Piramal Pharma has informed that it enclosed the Press Release and the Investor Presentation on the Financial Results. The above information is also available on the website of the Company at https://www.piramalpharma.com/.
The above information is a part of company’s filings submitted to BSE.
